Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Operations (2016 - 2026)

Organogenesis Holdings has reported Cash from Operations over the past 10 years, most recently at 39420000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 260.43% year-over-year to 39420000.0; the TTM value through Dec 2025 reached 10309000.0, down 172.56%, while the annual FY2025 figure was 10309000.0, 172.56% down from the prior year.
  • Cash from Operations for Q4 2025 was 39420000.0 at Organogenesis Holdings, up from 3079000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 39420000.0 in Q4 2025 and troughed at 32873000.0 in Q2 2025.
  • A 5-year average of 6082650.0 and a median of 8223000.0 in 2022 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 287.25% in 2021 and later plummeted 793.82% in 2025.
  • Year by year, Cash from Operations stood at 17948000.0 in 2021, then plummeted by 56.54% to 7800000.0 in 2022, then soared by 36.08% to 10614000.0 in 2023, then increased by 3.04% to 10937000.0 in 2024, then skyrocketed by 260.43% to 39420000.0 in 2025.
  • Business Quant data shows Cash from Operations for ORGO at 39420000.0 in Q4 2025, 3079000.0 in Q3 2025, and 32873000.0 in Q2 2025.